StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3076% above fair value
$266.17−4.39 (-1.62%)

Close on Nov 3, 2026Market cap $641.44BP/E 40.4Yield 1.93%

Johnson & Johnson J&J Savings Plan by Year

J&J Savings Plan — Plan interest in Master Trust net investment income ($) ($)

Johnson & Johnson J&J Savings Plan: $4,507,325,830 in FY2025, up 74.7% from a year earlier.

Latest, FY2025
4,507,325,830
Period ended Dec 28, 2025
Change on a year earlier
+74.7%
2,579,586,046 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below

Where the FY2025 figure comes from

“|| Plan's interest in the Johnson & Johnson Pension and Savings Plans Master Trust net investment income/loss | $ | 4,507,325,830”

Source: Form 11-K (Savings Plan) (jnj-20260624.htm, filed 2026-06-25) ↗

Reported in Form 11-K Statement of Changes in Net Assets.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Johnson & Johnson J&J Savings Plan ($), annual FY2019–FY2025 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/sp-net-inv-income

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.

See a number that looks wrong?